WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
QUICK SEARCH:   [advanced]


     
-


HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (205)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nagayama, T.
Right arrow Articles by Greenberg, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nagayama, T.
Right arrow Articles by Greenberg, D. A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*GLUCOSE
Medline Plus Health Information
*Transient Ischemic Attack

 Previous Article  |  Next Article 

The Journal of Neuroscience, April 15, 1999, 19(8):2987-2995

Cannabinoids and Neuroprotection in Global and Focal Cerebral Ischemia and in Neuronal Cultures

Tetsuya Nagayama1, Amy D. Sinor1, 2, Roger P. Simon1, Jun Chen1, Steven H. Graham1, Kunlin Jin1, and David A. Greenberg1, 2

Departments of 1 Neurology and 2 Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213

Marijuana and related drugs (cannabinoids) have been proposed as treatments for a widening spectrum of medical disorders. R(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazin-yl]-(1-naphthalenyl)methanone mesylate (R(+)-WIN 55212-2), a synthetic cannabinoid agonist, decreased hippocampal neuronal loss after transient global cerebral ischemia and reduced infarct volume after permanent focal cerebral ischemia induced by middle cerebral artery occlusion in rats. The less active enantiomer S(-)-WIN 55212-3 was ineffective, and the protective effect of R(+)-WIN 55212-2 was blocked by the specific central cannabinoid (CB1) cannabinoid receptor antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide-hydrochloride. R(+)-WIN 55212-2 also protected cultured cerebral cortical neurons from in vitro hypoxia and glucose deprivation, but in contrast to the receptor-mediated neuroprotection observed in vivo, this in vitro effect was not stereoselective and was insensitive to CB1 and CB2 receptor antagonists. Cannabinoids may have therapeutic potential in disorders resulting from cerebral ischemia, including stroke, and may protect neurons from injury through a variety of mechanisms.

Key words: cannabinoid; ischemia; stroke; glutamate; excitotoxicity; infarct; neuronal culture

Copyright © 1999 Society for Neuroscience  0270-6474/99/1982987-09$05.00/0


This article has been cited by other articles:


Home page
 Physiol. Rev.Home page
M. Kano, T. Ohno-Shosaku, Y. Hashimotodani, M. Uchigashima, and M. Watanabe
Endocannabinoid-Mediated Control of Synaptic Transmission
Physiol Rev, January 1, 2009; 89(1): 309 - 380.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
H. J. Kim, J. J. Waataja, and S. A. Thayer
Cannabinoids Inhibit Network-Driven Synapse Loss between Hippocampal Neurons in Culture
J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 850 - 858.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
A. Ludanyi, L. Eross, S. Czirjak, J. Vajda, P. Halasz, M. Watanabe, M. Palkovits, Z. Magloczky, T. F. Freund, and I. Katona
Downregulation of the CB1 Cannabinoid Receptor and Related Molecular Elements of the Endocannabinoid System in Epileptic Human Hippocampus
J. Neurosci., March 19, 2008; 28(12): 2976 - 2990.
[Abstract] [Full Text] [PDF]

Home page
 J. Neuropsychiatry Clin. Neurosi.Home page
P. Papathanasopoulos, L. Messinis, E. Lyros, A. Kastellakis, and G. Panagis
Multiple Sclerosis, Cannabinoids, and Cognition
J Neuropsychiatry Clin Neurosci, February 1, 2008; 20(1): 36 - 51.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
T. P. Obrenovitch
Molecular Physiology of Preconditioning-Induced Brain Tolerance to Ischemia
Physiol Rev, January 1, 2008; 88(1): 211 - 247.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
D. A. Karanian, S. L. Karim, J. T. Wood, J. S. Williams, S. Lin, A. Makriyannis, and B. A. Bahr
Endocannabinoid Enhancement Protects against Kainic Acid-Induced Seizures and Associated Brain Damage
J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1059 - 1066.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
G. Cao, J. Xing, X. Xiao, A. K. F. Liou, Y. Gao, X.-M. Yin, R. S. B. Clark, S. H. Graham, and J. Chen
Critical Role of Calpain I in Mitochondrial Release of Apoptosis-Inducing Factor in Ischemic Neuronal Injury
J. Neurosci., August 29, 2007; 27(35): 9278 - 9293.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Aguado, E. Romero, K. Monory, J. Palazuelos, M. Sendtner, G. Marsicano, B. Lutz, M. Guzman, and I. Galve-Roperh
The CB1 Cannabinoid Receptor Mediates Excitotoxicity-induced Neural Progenitor Proliferation and Neurogenesis
J. Biol. Chem., August 17, 2007; 282(33): 23892 - 23898.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
S. Batkai, D. Osei-Hyiaman, H. Pan, O. El-Assal, M. Rajesh, P. Mukhopadhyay, F. Hong, J. Harvey-White, A. Jafri, G. Hasko, et al.
Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury
FASEB J, June 1, 2007; 21(8): 1788 - 1800.
[Abstract] [Full Text] [PDF]

Home page
 NeuroscientistHome page
I. Galve-Roperh, T. Aguado, J. Palazuelos, and M. Guzman
The Endocannabinoid System and Neurogenesis in Health and Disease
Neuroscientist, April 1, 2007; 13(2): 109 - 114.
[Abstract] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. H. Kim, S. J. Won, X. O. Mao, C. Ledent, K. Jin, and D. A. Greenberg
Role for Neuronal Nitric-Oxide Synthase in Cannabinoid-Induced Neurogenesis
J. Pharmacol. Exp. Ther., October 1, 2006; 319(1): 150 - 154.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
P. Pacher, S. Batkai, and G. Kunos
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pharmacol. Rev., September 1, 2006; 58(3): 389 - 462.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
L. G. Bilsland, J. R. T. Dick, G. Pryce, S. Petrosino, V. Di Marzo, D. Baker, and L. Greensmith
Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice
FASEB J, May 1, 2006; 20(7): 1003 - 1005.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. Witting, L. Chen, E. Cudaback, A. Straiker, L. Walter, B. Rickman, T. Moller, C. Brosnan, and N. Stella
From the Cover: Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection
PNAS, April 18, 2006; 103(16): 6362 - 6367.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
E. Shohami and R. Mechoulam
Multiple sclerosis may disrupt endocannabinoid brain protection mechanism
PNAS, April 18, 2006; 103(16): 6087 - 6088.
[Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
S. H. Kim, S. J. Won, X. O. Mao, K. Jin, and D. A. Greenberg
Molecular Mechanisms of Cannabinoid Protection from Neuronal Excitotoxicity
Mol. Pharmacol., March 1, 2006; 69(3): 691 - 696.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
D. A. Karanian, Q. B. Brown, A. Makriyannis, T. A. Kosten, and B. A. Bahr
Dual Modulation of Endocannabinoid Transport and Fatty Acid Amide Hydrolase Protects against Excitotoxicity
J. Neurosci., August 24, 2005; 25(34): 7813 - 7820.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
D. J. Rademacher, S. Patel, W.-S. V. Ho, A. M. Savoie, N. J. Rusch, K. M. Gauthier, and C. J. Hillard
U-46619 but not serotonin increases endocannabinoid content in middle cerebral artery: evidence for functional relevance
Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2694 - H2701.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. H. Kim, S. J. Won, X. O. Mao, K. Jin, and D. A. Greenberg
Involvement of Protein Kinase A in Cannabinoid Receptor-Mediated Protection from Oxidative Neuronal Injury
J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 88 - 94.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
B. G. Ramirez, C. Blazquez, T. G. del Pulgar, M. Guzman, and M. L. de Ceballos
Prevention of Alzheimer's Disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockade of Microglial Activation
J. Neurosci., February 23, 2005; 25(8): 1904 - 1913.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
K. Jin, L. Xie, S. H. Kim, S. Parmentier-Batteur, Y. Sun, X. O. Mao, J. Childs, and D. A. Greenberg
Defective Adult Neurogenesis in CB1 Cannabinoid Receptor Knockout Mice
Mol. Pharmacol., August 1, 2004; 66(2): 204 - 208.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
T. Geller, L. Loftis, and D. S. Brink
Cerebellar Infarction in Adolescent Males Associated With Acute Marijuana Use
Pediatrics, April 1, 2004; 113(4): e365 - e370.
[Abstract] [Full Text] [PDF]

Home page
 AM J HOSP PALLIAT CAREHome page
D. Amtmann, P. Weydt, K. L. Johnson, M. P. Jensen, and G. T. Carter
Survey of cannabis use in patients with amyotrophic lateral sclerosis
American Journal of Hospice and Palliative Medicine, March 1, 2004; 21(2): 95 - 104.
[Abstract] [PDF]

Home page
 Am. J. Pathol.Home page
A. B. El-Remessy, I. E. Khalil, S. Matragoon, G. Abou-Mohamed, N.-J. Tsai, P. Roon, R. B. Caldwell, R. W. Caldwell, K. Green, and G. I. Liou
Neuroprotective Effect of(-){Delta}9-Tetrahydrocannabinol and Cannabidiol in N-Methyl-D-Aspartate-Induced Retinal Neurotoxicity: Involvement of Peroxynitrite
Am. J. Pathol., November 1, 2003; 163(5): 1997 - 2008.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
G. Pryce, Z. Ahmed, D. J. R. Hankey, S. J. Jackson, J. L. Croxford, J. M. Pocock, C. Ledent, A. Petzold, A. J. Thompson, G. Giovannoni, et al.
Cannabinoids inhibit neurodegeneration in models of multiple sclerosis
Brain, October 1, 2003; 126(10): 2191 - 2202.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
A. Franklin, S. Parmentier-Batteur, L. Walter, D. A. Greenberg, and N. Stella
Palmitoylethanolamide Increases after Focal Cerebral Ischemia and Potentiates Microglial Cell Motility
J. Neurosci., August 27, 2003; 23(21): 7767 - 7775.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
R. R. Leker, N. Gai, R. Mechoulam, and H. Ovadia
Drug-Induced Hypothermia Reduces Ischemic Damage: Effects of the Cannabinoid HU-210
Stroke, August 1, 2003; 34(8): 2000 - 2006.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
F. Molina-Holgado, E. Pinteaux, J. D. Moore, E. Molina-Holgado, C. Guaza, R. M. Gibson, and N. J. Rothwell
Endogenous Interleukin-1 Receptor Antagonist Mediates Anti-Inflammatory and Neuroprotective Actions of Cannabinoids in Neurons and Glia
J. Neurosci., July 23, 2003; 23(16): 6470 - 6474.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
L. Iversen
Cannabis and the brain
Brain, June 1, 2003; 126(6): 1252 - 1270.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
W. B. Veldhuis, M. van der Stelt, M. W. Wadman, G. van Zadelhoff, M. Maccarrone, F. Fezza, G. A. Veldink, J. F. G. Vliegenthart, P. R. Bar, K. Nicolay, et al.
Neuroprotection by the Endogenous Cannabinoid Anandamide and Arvanil against In Vivo Excitotoxicity in the Rat: Role of Vanilloid Receptors and Lipoxygenases
J. Neurosci., May 15, 2003; 23(10): 4127 - 4133.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
E. Molina-Holgado, J. M. Vela, A. Arevalo-Martin, G. Almazan, F. Molina-Holgado, J. Borrell, and C. Guaza
Cannabinoids Promote Oligodendrocyte Progenitor Survival: Involvement of Cannabinoid Receptors and Phosphatidylinositol-3 Kinase/Akt Signaling
J. Neurosci., November 15, 2002; 22(22): 9742 - 9753.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
S. Parmentier-Batteur, K. Jin, X. O. Mao, L. Xie, and D. A. Greenberg
Increased Severity of Stroke in CB1 Cannabinoid Receptor Knock-Out Mice
J. Neurosci., November 15, 2002; 22(22): 9771 - 9775.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
S. Parmentier-Batteur, K. Jin, L. Xie, X. O. Mao, and D. A. Greenberg
DNA Microarray Analysis of Cannabinoid Signaling in Mouse Brain in Vivo
Mol. Pharmacol., October 1, 2002; 62(4): 828 - 835.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Gomez del Pulgar, M. L. de Ceballos, M. Guzman, and G. Velasco
Cannabinoids Protect Astrocytes from Ceramide-induced Apoptosis through the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway
J. Biol. Chem., September 20, 2002; 277(39): 36527 - 36533.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
W.-R. Schabitz, A. Giuffrida, C. Berger, A. Aschoff, M. Schwaninger, S. Schwab, and D. Piomelli
Release of Fatty Acid Amides in a Patient With Hemispheric Stroke: A Microdialysis Study
Stroke, August 1, 2002; 33(8): 2112 - 2114.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
F. Mauler, J. Mittendorf, E. Horvath, and J. de Vry
Characterization of the Diarylether Sulfonylester (-)-(R)-3-(2-Hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluoro-1-sulfonate (BAY 38-7271) as a Potent Cannabinoid Receptor Agonist with Neuroprotective Properties
J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 359 - 368.
[Abstract] [Full Text] [PDF]

Home page
 Sci SignalHome page
R. Mechoulam, M. Spatz, and E. Shohami
Endocannabinoids and Neuroprotection
Sci. Signal., April 23, 2002; 2002(129): re5 - re5.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
M. van der Stelt, W. B. Veldhuis, G. W. van Haaften, F. Fezza, T. Bisogno, P. R. Bar, G. A. Veldink, J. F. G. Vliegenthart, V. Di Marzo, and K. Nicolay
Exogenous Anandamide Protects Rat Brain against Acute Neuronal Injury In Vivo
J. Neurosci., November 15, 2001; 21(22): 8765 - 8771.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
M. van der Stelt, W. B. Veldhuis, P. R. Bar, G. A. Veldink, J. F. G. Vliegenthart, and K. Nicolay
Neuroprotection by {Delta}9-Tetrahydrocannabinol, the Main Active Compound in Marijuana, against Ouabain-Induced In Vivo Excitotoxicity
J. Neurosci., September 1, 2001; 21(17): 6475 - 6479.
[Abstract] [Full Text] [PDF]

Home page
 AM J HOSP PALLIAT CAREHome page
G. T. Carter and B. S. Rosen
Marijuana in the management of amyotrophic lateral sclerosis
American Journal of Hospice and Palliative Medicine, July 1, 2001; 18(4): 264 - 270.
[Abstract] [PDF]

Home page
 J. Neurosci.Home page
G. Cao, W. Pei, J. Lan, R. A. Stetler, Y. Luo, T. Nagayama, S. H. Graham, X.-M. Yin, R. P. Simon, and J. Chen
Caspase-Activated DNase/DNA Fragmentation Factor 40 Mediates Apoptotic DNA Fragmentation in Transient Cerebral Ischemia and in Neuronal Cultures
J. Neurosci., July 1, 2001; 21(13): 4678 - 4690.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
B. Moesgaard, G. Petersen, J. W. Jaroszewski, and H. S. Hansen
Age dependent accumulation of N-acyl-ethanolamine phospholipids in ischemic rat brain: a 31P NMR and enzyme activity study
J. Lipid Res., June 1, 2000; 41(6): 985 - 990.
[Abstract] [Full Text]


-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help
-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-